ATE318601T1 - Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten - Google Patents

Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Info

Publication number: ATE318601T1
Authority: AT; Austria
Prior art keywords: compositions; xylometazoline; running; treatment; salt
Prior art date: 2001-09-18

Application number

AT02765268T

Other languages

English (en)

Inventor

Hanne Anette Moesgaard

Karin Lowenstein Christensen

Original Assignee

Nycomed Danmark Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-18

Filing date

2002-09-18

Publication date

2006-03-15

2002-09-18 Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps

2006-03-15 Application granted granted Critical

2006-03-15 Publication of ATE318601T1 publication Critical patent/ATE318601T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
229960001888 ipratropium Drugs 0.000 title abstract 2
HUCJFAOMUPXHDK-UHFFFAOYSA-N Xylometazoline Chemical compound CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCCN1 HUCJFAOMUPXHDK-UHFFFAOYSA-N 0.000 title 2
OEXHQOGQTVQTAT-SSZRJXQFSA-N [(1r,5s)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] (2r)-3-hydroxy-2-phenylpropanoate Chemical compound C1([C@H](CO)C(=O)OC2C[C@H]3CC[C@@H](C2)[N+]3(C)C(C)C)=CC=CC=C1 OEXHQOGQTVQTAT-SSZRJXQFSA-N 0.000 title 1
229960000833 xylometazoline Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
YGWFCQYETHJKNX-UHFFFAOYSA-N 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCC[NH2+]1 YGWFCQYETHJKNX-UHFFFAOYSA-N 0.000 abstract 1
208000036071 Rhinorrhea Diseases 0.000 abstract 1
206010039101 Rhinorrhoea Diseases 0.000 abstract 1
239000000812 cholinergic antagonist Substances 0.000 abstract 1
OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
210000002850 nasal mucosa Anatomy 0.000 abstract 1
201000009240 nasopharyngitis Diseases 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000005526 vasoconstrictor agent Substances 0.000 abstract 1
229960001095 xylometazoline hydrochloride Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Polyurethanes Or Polyureas (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Cosmetics (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT02765268T 2001-09-18 2002-09-18 Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten ATE318601T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200101356		2001-09-18

Publications (1)

Publication Number	Publication Date
ATE318601T1 true ATE318601T1 (de)	2006-03-15

Family

ID=8160714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02765268T ATE318601T1 (de)	2001-09-18	2002-09-18	Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Country Status (20)

Country	Link
US (2)	US7652030B2 (de)
EP (2)	EP1661570A3 (de)
JP (1)	JP4500045B2 (de)
KR (1)	KR100810872B1 (de)
CN (1)	CN1290502C (de)
AT (1)	ATE318601T1 (de)
BR (1)	BRPI0212586B8 (de)
CA (1)	CA2460140C (de)
DE (1)	DE60209511T2 (de)
DK (1)	DK1446119T3 (de)
EA (1)	EA008165B1 (de)
ES (1)	ES2259098T3 (de)
HU (1)	HU226527B1 (de)
MX (1)	MXPA04002500A (de)
NO (1)	NO334441B1 (de)
NZ (1)	NZ531792A (de)
PL (1)	PL208686B1 (de)
PT (1)	PT1446119E (de)
SI (1)	SI1446119T1 (de)
WO (1)	WO2003024433A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
NZ531792A (en) *	2001-09-18	2006-02-24	Nycomed Danmark Aps	Compositions for treatment of common cold
TWI359675B (en) *	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
RU2006132043A (ru) *	2004-02-06	2008-03-20	МЕДА Фарма ГмбХ унд Ко.КГ (DE)	Комбинация и фармацевтический препарат для лечения ринита
WO2005084330A2 (en) *	2004-03-02	2005-09-15	Synergia Pharma, Inc.	Compositions and methods for treating nasal congestion
DE102004049008A1 (de) *	2004-10-05	2006-04-06	Merck Patent Gmbh	Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US8481565B2 (en) *	2004-12-27	2013-07-09	Eisai R&D Management Co., Ltd.	Method for stabilizing anti-dementia drug
DE102006023770A1 (de) *	2006-05-20	2007-11-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (de)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
US20090270472A1 (en) *	2008-04-25	2009-10-29	Kenneth Gould	Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de)	2009-03-31	2013-10-23	Boehringer Ingelheim International GmbH	Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de)	2009-05-18	2020-12-23	Boehringer Ingelheim International GmbH	Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es)	2009-11-25	2012-06-14	Boehringer Ingelheim Int	Nebulizador.
JP5658268B2 (ja)	2009-11-25	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
JP5874724B2 (ja)	2010-06-24	2016-03-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
WO2012130757A1 (de)	2011-04-01	2012-10-04	Boehringer Ingelheim International Gmbh	Medizinisches gerät mit behälter
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013152894A1 (de)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Zerstäuber mit kodiermitteln
WO2014158118A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş.	Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş	Aqueous solution composition containing ipratropium and oxymetazoline
EP2835146B1 (de)	2013-08-09	2020-09-30	Boehringer Ingelheim International GmbH	Zerstäuber
WO2015018904A1 (en)	2013-08-09	2015-02-12	Boehringer Ingelheim International Gmbh	Nebulizer
WO2015054359A1 (en) *	2013-10-08	2015-04-16	Ebadi Mark A	Methods and compositions for symptomatic reflief of the common cold
BR122022010094B1 (pt)	2014-05-07	2023-10-03	Boehringer Ingelheim International Gmbh	Dispositivo indicador e recipiente
WO2015169430A1 (en)	2014-05-07	2015-11-12	Boehringer Ingelheim International Gmbh	Nebulizer
MX383195B (es)	2014-05-07	2025-03-13	Boehringer Ingelheim Int	Recipiente, nebulizador y uso.
EP3236933B1 (de)	2014-12-24	2018-11-14	JADRAN - GALENSKI LABORATORIJ d.d.	Nasale zusammensetzung mit meerwasser als stabilitätsverbessernder hilfsstoff
MX383771B (es) *	2015-12-02	2025-03-14	Pablo Cortes Borrego	Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) *	2020-07-31	2022-02-03	Eye Therapies Llc	Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69229880T2 (de) *	1991-11-19	2000-05-04	The University Of Virginia Patent Foundation, Charlottesville	Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en) *	1992-02-24	1997-03-18	Res & Dev Co Ltd	Composition for nasal treatment
GB9218834D0 (en)	1992-09-05	1992-10-21	Procter & Gamble	Nasal spray products
EP0673240B1 (de)	1992-12-09	1999-03-24	Boehringer Ingelheim Pharmaceuticals Inc.	Stabilisierte medizinische aerosollösungen
EP0780127A1 (de)	1995-12-19	1997-06-25	The Procter & Gamble Company	Nasenspray enthaltend einen Steroid und einen Antihistamin
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
CA2281789A1 (en) *	1997-04-30	1998-11-05	Warner-Lambert Company	Topical nasal antiinflammatory compositions
DE69901936T2 (de) *	1998-01-30	2002-11-28	Novartis Consumer Health S.A., Nyon	Nasale lösungen
KR100600423B1 (ko)	1998-06-18	2006-07-13	베링거 인겔하임 파마슈티칼즈, 인코포레이티드	2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형
WO2000078297A2 (de) *	1999-06-22	2000-12-28	Boehringer Ingelheim International Gmbh	Stabile xylometazolin- und oxymetazolinlösung
NZ531792A (en) *	2001-09-18	2006-02-24	Nycomed Danmark Aps	Compositions for treatment of common cold

2002
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
- 2002-09-18 EP EP06075452A patent/EP1661570A3/de not_active Withdrawn
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 EP EP02765268A patent/EP1446119B1/de not_active Expired - Lifetime
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0402075A2 (hu)	2005-02-28
JP4500045B2 (ja)	2010-07-14
BRPI0212586B8 (pt)	2021-05-25
KR100810872B1 (ko)	2008-03-06
EP1446119A2 (de)	2004-08-18
CN1555263A (zh)	2004-12-15
US7652030B2 (en)	2010-01-26
WO2003024433A2 (en)	2003-03-27
EP1661570A3 (de)	2012-10-24
DE60209511D1 (de)	2006-04-27
WO2003024433A3 (en)	2004-06-10
BR0212586B1 (pt)	2013-11-19
MXPA04002500A (es)	2004-11-22
EA200400444A1 (ru)	2005-02-24
HK1067984A1 (en)	2005-04-22
PL370536A1 (en)	2005-05-30
BR0212586A (pt)	2004-10-13
CA2460140C (en)	2009-09-01
NZ531792A (en)	2006-02-24
CA2460140A1 (en)	2003-03-27
CN1290502C (zh)	2006-12-20
US20040248924A1 (en)	2004-12-09
ES2259098T3 (es)	2006-09-16
NO20041070L (no)	2004-05-18
EP1661570A2 (de)	2006-05-31
EP1446119B1 (de)	2006-03-01
PL208686B1 (pl)	2011-05-31
HU226527B1 (hu)	2009-03-30
HUP0402075A3 (en)	2008-04-28
SI1446119T1 (sl)	2006-08-31
DE60209511T2 (de)	2006-10-05
US8450339B2 (en)	2013-05-28
NO334441B1 (no)	2014-03-03
DK1446119T3 (da)	2006-07-10
US20100093783A1 (en)	2010-04-15
PT1446119E (pt)	2006-07-31
JP2005505569A (ja)	2005-02-24
KR20040049849A (ko)	2004-06-12
EA008165B1 (ru)	2007-04-27

Legal Events

Date

Code

Title

Description

2006-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1446119

Country of ref document: EP

Publication	Publication Date	Title
DE60209511D1 (de)	2006-04-27	Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
WO2005063297A3 (en)	2006-01-26	Melatonin combination therapy for improving sleep quality
NO2007010I2 (no)	2009-12-14	Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
WO2002085909A8 (en)	2004-04-29	9-deazaguanine derivatives as inhibitors of gsk-3
BR0212042A (pt)	2004-08-17	Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
GB0223040D0 (en)	2002-11-13	Therapeutic compounds
DE60043318D1 (de)	2010-01-14	Synergistische kombination von pumafentrine und salmeterol
ATE454378T1 (de)	2010-01-15	Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen
NO20050851L (no)	2005-03-29	Kaspase-inhibitorer og anvendelser derav
BR0307508A (pt)	2004-12-07	Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
PL374443A1 (en)	2005-10-17	Novel pyrimidineamide derivatives and the use thereof
ATE402175T1 (de)	2008-08-15	4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
MXPA03011466A (es)	2004-07-01	Macrociclos utiles en tratamiento de enfermedades de alzheimer.
EP1666064A4 (de)	2008-12-17	Mittel zur behandlung von erkrankungen im zusammenhang mit immunoglobulin-gen-translokation
RU2003127718A (ru)	2005-01-27	Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости
WO2006052899A3 (en)	2006-11-16	Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
DE60117541D1 (de)	2006-04-27	Candesartan zur Behandlung von Migräne
BG105984A (bg)	2002-04-30	Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
BR0112123A (pt)	2003-05-06	Composto
DE60215525D1 (de)	2006-11-30	Kombination aus quetiapin und zolmitriptan
ATE353221T1 (de)	2007-02-15	Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
ATE321554T1 (de)	2006-04-15	2-methylthiazolidin-2,4-dicarbonsaeure und deren salze zur behandlung von neurodegenerativen erkrankungen
TH55580A (th)	2003-03-07	สารประกอบแลคแทม
TH45761A (th)	2001-06-15	สารยับยั้งระบบการตัดไกลซีนที่มีศักยภาพเป็นสารต้านโรคจิต